The National Institutes of Health (NIH) invited the Front Line COVID-19 Critical Care Alliance (FLCCC) to present to this national research agency’s COVID-19 Treatment Guidelines Panel. The Panel, which is the most influential of any such group worldwide, now is taking the time to review the unfolding Ivermectin situation. Of course, such a meeting wouldn’t be possible if it were not for the dedicated, committed and relentless efforts of the physician/researchers’ embrace of a story that we have been chronicling since April. The FLCCC, led by Dr. Pierre Kory and Dr. Paul Marik, along with prominent British researcher, Dr. Andrew Hill, affiliated with the University of Liverpool in the UK, presented their respective meta-analysis findings to date.
TrialSite News Related News Articles:
NIH Updates its COVID-19 Guidelines for Ivermectin While FLCCC Pays a Visit to Hugh HewittNIH COVID-19 Treatment Guidelines Panel Invites Top Ivermectin Researchers to Discuss the Evidence of Efficacy to Date
WhiteboardDoctorDr. Kory radio interview:
Dr. Pierre Kory Of the FLCCC Alliance On The Therapeutic Value of Ivermectin in Treatment of Covid
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).